You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 3
  • 14 Phase II trial evaluating efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer

Citation Tools

Article menu

Download PDFPDF

Oral Plenary
Plenary V
IGCS20_1271
14 Phase II trial evaluating efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Nishikawa N, Shoji T, Enomoto T, et al
14 Phase II trial evaluating efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer
International Journal of Gynecologic Cancer 2020;30:A10-A11.